|
ES2165768B1
(es)
|
1999-07-14 |
2003-04-01 |
Almirall Prodesfarma Sa |
Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
|
|
MY140561A
(en)
|
2002-02-20 |
2009-12-31 |
Nycomed Gmbh |
Dosage form containing pde 4 inhibitor as active ingredient
|
|
EP1610787B1
(en)
*
|
2003-03-28 |
2008-01-23 |
Nycomed GmbH |
Synergistic combination comprising roflumilast and an anticholinergic agent selected from tiotropium salts for the treatment of respiratory diseases
|
|
MXPA05011225A
(es)
*
|
2003-04-18 |
2005-12-14 |
Pharmacia & Upjohn Co Llc |
Politerapias.
|
|
RS52730B
(sr)
*
|
2003-05-22 |
2013-08-30 |
Takeda Gmbh |
Kompozicija koja sadrži pde4 inhibitor i pde5 inhibitor
|
|
EP1651222A1
(en)
*
|
2003-07-29 |
2006-05-03 |
Boehringer Ingelheim International Gmbh |
Medicaments comprising pde iv inhibitors and an anticholinergic for treating respiratory disorders
|
|
EP1504756A1
(en)
*
|
2003-08-06 |
2005-02-09 |
Kyowa Hakko Kogyo Co., Ltd |
Medicament compositions comprising a heterocyclic compound and an anticholinergic
|
|
EP1713472A2
(en)
*
|
2004-02-06 |
2006-10-25 |
MEDA Pharma GmbH & Co. KG |
Treatment of rhinitis with anticholinergics alone in combination with antihistamines phosphodiesterase 4 inhibitors, or corticosteroids
|
|
CN100569235C
(zh)
|
2004-02-06 |
2009-12-16 |
Meda制药有限及两合公司 |
用于哮喘和copd长期治疗的抗胆碱能药和糖皮质激素的组合
|
|
WO2005074982A2
(en)
*
|
2004-02-06 |
2005-08-18 |
Meda Pharma Gmbh & Co. Kg |
Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory diseases
|
|
US7507745B2
(en)
|
2004-02-20 |
2009-03-24 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical compositions based on fluorenecarboxylic acid esters and soluble TNF receptor fusion proteins
|
|
CA2553369A1
(en)
*
|
2004-02-20 |
2005-09-01 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical compositions based on anticholinergics and pegsunercept
|
|
ES2257152B1
(es)
*
|
2004-05-31 |
2007-07-01 |
Laboratorios Almirall S.A. |
Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos.
|
|
PT1905451E
(pt)
*
|
2004-05-31 |
2010-03-31 |
Almirall Sa |
Combinações que compreendem agentes antimuscarínicos e corticosteróides
|
|
US20060079544A1
(en)
*
|
2004-08-13 |
2006-04-13 |
Boehringer Ingelheim International Gmbh |
Medicaments for the prevention or treatment of alveolar pneumonia comprising an anticholinergic
|
|
CN101128196B
(zh)
|
2005-03-16 |
2013-01-02 |
Meda制药有限及两合公司 |
用于治疗呼吸系统疾病的抗胆碱能药和白三烯受体拮抗剂的组合
|
|
EP1875915A4
(en)
*
|
2005-04-28 |
2010-11-17 |
Dainippon Sumitomo Pharma Co |
THERAPEUTIC AGENT FOR TREATING CHRONIC OBSTRUCTIVE RESPIRATORY DISEASE
|
|
DE102005035112A1
(de)
*
|
2005-07-27 |
2007-02-15 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neues Verfahren zur Herstellung von Tiotropiumsalzen unter Anwendung von in organischen Lösungsmitteln löslichen N-Methylscopiniumsalzen
|
|
EP2258358A3
(en)
|
2005-08-26 |
2011-09-07 |
Braincells, Inc. |
Neurogenesis with acetylcholinesterase inhibitor
|
|
US7678363B2
(en)
|
2005-08-26 |
2010-03-16 |
Braincells Inc |
Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIs
|
|
EP2377530A3
(en)
|
2005-10-21 |
2012-06-20 |
Braincells, Inc. |
Modulation of neurogenesis by PDE inhibition
|
|
EP1942879A1
(en)
|
2005-10-31 |
2008-07-16 |
Braincells, Inc. |
Gaba receptor mediated modulation of neurogenesis
|
|
PL1971369T3
(pl)
|
2005-12-21 |
2010-01-29 |
Meda Pharma Gmbh & Co Kg |
Połączenie R,R-glikopirolanu, rolipramu i budesonidu dla potrzeb leczenia chorób zapalnych
|
|
US20100216734A1
(en)
|
2006-03-08 |
2010-08-26 |
Braincells, Inc. |
Modulation of neurogenesis by nootropic agents
|
|
WO2007134136A2
(en)
|
2006-05-09 |
2007-11-22 |
Braincells, Inc. |
Neurogenesis by modulating angiotensin
|
|
EP1905440A1
(de)
*
|
2006-09-06 |
2008-04-02 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Verwendung einer pharmazeutischen Zusammensetzung enthaltend ein Anticholinergikum zur Abtötung von Mikroorganismen und zur Behandlung von Atemwegsinfektionen
|
|
US20100184806A1
(en)
|
2006-09-19 |
2010-07-22 |
Braincells, Inc. |
Modulation of neurogenesis by ppar agents
|
|
EP2100599A1
(en)
|
2008-03-13 |
2009-09-16 |
Laboratorios Almirall, S.A. |
Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
|
|
EP2100598A1
(en)
|
2008-03-13 |
2009-09-16 |
Laboratorios Almirall, S.A. |
Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
|
|
US20100216805A1
(en)
|
2009-02-25 |
2010-08-26 |
Braincells, Inc. |
Modulation of neurogenesis using d-cycloserine combinations
|
|
HRP20140520T1
(hr)
*
|
2009-06-18 |
2014-07-04 |
Concert Pharmaceuticals Inc. |
Deuterirani derivati izoindolin-1,3-diona kao inhibitori pde4 i tnf-alfa
|
|
EP2510928A1
(en)
|
2011-04-15 |
2012-10-17 |
Almirall, S.A. |
Aclidinium for use in improving the quality of sleep in respiratory patients
|
|
US20150119399A1
(en)
|
2012-01-10 |
2015-04-30 |
President And Fellows Of Harvard College |
Beta-cell replication promoting compounds and methods of their use
|